TLR4 and type 2 diabetes mellitus: Experimental studies have shown that T2DM patients exhibit a fivefold increase in TLR4 expression in monocytes compared to non-diabetic controls, suggesting that enhanced inflammatory signaling in monocytes may exacerbate diabetes progression (26, 27).